Pricing Log in Create free account

Virax Biolabs Group Limited (VRAX) vs Windtree Therapeutics, Inc. (WINT)

Virax Biolabs Group Limited and Windtree Therapeutics, Inc. are both Biotechnology companies. Virax Biolabs Group Limited and Windtree Therapeutics, Inc. are of similar size ($2.4M and $2.2M). Across the 9 metrics below, Windtree Therapeutics, Inc. leads on 5 and Virax Biolabs Group Limited on 4.

Valuation

Metric VRAX WINT Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.86 n/m 0.64
EV/Sales n/m 63.80 9.21
Earnings yield (367.59%) 0.00% (33.15%)
Free cash flow yield 0.00% 0.00% (25.50%)

Profitability

Metric VRAX WINT Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin — 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 1,356.23% (56.36%)
Return on assets 0.00% (210.34%) (48.04%)
Return on invested capital 0.00% (386.34%) 0.00%

Growth

Metric VRAX WINT Biotechnology median
Revenue growth (TTM) — (68.35%) 6.02%
EPS growth (last fiscal year) 68.79% 97.79% 30.26%
Revenue growth, 5-year CAGR (36.88%) (41.28%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric VRAX WINT Biotechnology median
Debt to equity 0.00 (1.48) 0.00
Current ratio 9.97 0.33 4.72
Net debt to EBITDA 1.08 0.03 0.96

Dividend

Metric VRAX WINT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric VRAX WINT Biotechnology median
Market cap 2.18m 2.35m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack